Sysmex (OTCMKTS:SSMXY) Releases FY 2024 Earnings Guidance

Sysmex (OTCMKTS:SSMXY) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.590-0.590 for the period. The company issued revenue guidance of $3.4 billion-$3.4 billion.

Sysmex Trading Up 3.7 %

Shares of OTCMKTS SSMXY opened at $20.44 on Friday. The stock’s 50 day moving average price is $19.24 and its two-hundred day moving average price is $17.63. Sysmex has a 52-week low of $14.38 and a 52-week high of $29.78. The stock has a market capitalization of $12.86 billion, a P/E ratio of 37.16 and a beta of 0.84. The company has a quick ratio of 2.40, a current ratio of 3.23 and a debt-to-equity ratio of 0.11.

Sysmex (OTCMKTS:SSMXY) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.11 earnings per share (EPS) for the quarter. The firm had revenue of $718.13 million for the quarter. On average, analysts anticipate that Sysmex will post 0.57 earnings per share for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.